Search Results Search Sort by RelevanceMost Recent State of the Art and Science Nov 2004 Chronic Myeloid Leukemia and the Application of Rational Drug Design Richard Maury Stone, MD Imatinib is a pharmaceutical therapy recently approved by the FDA to help treat chronic myeloid leukemia. Virtual Mentor. 2004;6(11):497-500. doi: 10.1001/virtualmentor.2004.6.11.cprl1-0411. Health Law Nov 2004 Wright v. Fred Hutchinson Cancer Center: Maintaining Patient and Public Trust in Clinical Research Laura Lin, MBA and Bryan A. Liang, MD, PhD, JD An ethical case explores a lawsuit against Fred Hutchinson Cancer Center of Seattle by patients who claimed they were not told of the full risks associated with a clinical trial they participated in. Virtual Mentor. 2004;6(11):501-504. doi: 10.1001/virtualmentor.2004.6.11.hlaw1-0411. Medicine and Society Nov 2004 Gatekeeping and the FDA's Role in Human Subjects Protection Daniel Carpenter, PhD The FDA bears the responsibility to monitor clinical trials and protect human subjects from harm. Virtual Mentor. 2004;6(11):512-514. doi: 10.1001/virtualmentor.2004.6.11.msoc1-0411. Policy Forum Nov 2004 Genetic Samples and Genetic Philanthropy Michael E. Berens, PhD and Gary E. Marchant, PhD, JD Genetic research is threatened by lack of samples, and public policy should be developed to encourage public participation. Virtual Mentor. 2004;6(11):509-511. doi: 10.1001/virtualmentor.2004.6.11.pfor2-0411. In the Literature Nov 2004 Determining Research through Underdetermined Treatment Abraham P. Schwab, PhD Paul Miller and Charles Weijer defend the concept of equipoise in medical research in a recent journal article. Virtual Mentor. 2004;6(11):488-489. doi: 10.1001/virtualmentor.2004.6.11.jdsc1-0411. Policy Forum Mar 2004 Content of Medical Error Disclosures Thomas H. Gallagher, MD A basic standard for error disclosure for physicians needs to be developed, which will enhance the patient-physician relationship. Virtual Mentor. 2004;6(3):132-135. doi: 10.1001/virtualmentor.2004.6.3.pfor1-0403. Case and Commentary Mar 2004 HMO-Dictated Patient Discharge, Commentary 2 Linda MacDonald Glenn, JD, LLM The financial constraints of HMOs often conflict with physicians' medical decisions regarding patient care. Virtual Mentor. 2004;6(3):112-116. doi: 10.1001/virtualmentor.2004.6.3.ccas3-0403. Case and Commentary Mar 2004 HMO-Dictated Patient Discharge, Commentary 1 Lisa Anderson-Shaw, DrPH, MA, MSN The financial constraints of HMOs often conflict with physicians' medical decisions regarding patient care. Virtual Mentor. 2004;6(3):112-116. doi: 10.1001/virtualmentor.2004.6.3.ccas3-0403. In the Literature Mar 2004 Leap-Frogging to Forgiveness Faith Lagay, PhD A journal author calls for physicians to admit to and repent for their medical mistakes, even in a no-blame environment. Virtual Mentor. 2004;6(3):117-119. doi: 10.1001/virtualmentor.2004.6.3.jdsc1-0403. Case and Commentary Nov 2004 Clinical Trials and End-of-Life Decision Making, Commentary 2 Lucy Godley, MD, PhD Physicians can help oncology patients decide whether to focus on aggressive chemotherapy or less aggressive comfort measures for end-of-life care. Virtual Mentor. 2004;6(11):479-481. doi: 10.1001/virtualmentor.2004.6.11.ccas1-0411. Pagination First page « First Previous page ‹ Previous … Page 13 Page 14 Page 15 Page 16 Page 17 Page 18 Page 19 Current page 20 Page 21 Next page Next › Last page Last »
State of the Art and Science Nov 2004 Chronic Myeloid Leukemia and the Application of Rational Drug Design Richard Maury Stone, MD Imatinib is a pharmaceutical therapy recently approved by the FDA to help treat chronic myeloid leukemia. Virtual Mentor. 2004;6(11):497-500. doi: 10.1001/virtualmentor.2004.6.11.cprl1-0411.
Health Law Nov 2004 Wright v. Fred Hutchinson Cancer Center: Maintaining Patient and Public Trust in Clinical Research Laura Lin, MBA and Bryan A. Liang, MD, PhD, JD An ethical case explores a lawsuit against Fred Hutchinson Cancer Center of Seattle by patients who claimed they were not told of the full risks associated with a clinical trial they participated in. Virtual Mentor. 2004;6(11):501-504. doi: 10.1001/virtualmentor.2004.6.11.hlaw1-0411.
Medicine and Society Nov 2004 Gatekeeping and the FDA's Role in Human Subjects Protection Daniel Carpenter, PhD The FDA bears the responsibility to monitor clinical trials and protect human subjects from harm. Virtual Mentor. 2004;6(11):512-514. doi: 10.1001/virtualmentor.2004.6.11.msoc1-0411.
Policy Forum Nov 2004 Genetic Samples and Genetic Philanthropy Michael E. Berens, PhD and Gary E. Marchant, PhD, JD Genetic research is threatened by lack of samples, and public policy should be developed to encourage public participation. Virtual Mentor. 2004;6(11):509-511. doi: 10.1001/virtualmentor.2004.6.11.pfor2-0411.
In the Literature Nov 2004 Determining Research through Underdetermined Treatment Abraham P. Schwab, PhD Paul Miller and Charles Weijer defend the concept of equipoise in medical research in a recent journal article. Virtual Mentor. 2004;6(11):488-489. doi: 10.1001/virtualmentor.2004.6.11.jdsc1-0411.
Policy Forum Mar 2004 Content of Medical Error Disclosures Thomas H. Gallagher, MD A basic standard for error disclosure for physicians needs to be developed, which will enhance the patient-physician relationship. Virtual Mentor. 2004;6(3):132-135. doi: 10.1001/virtualmentor.2004.6.3.pfor1-0403.
Case and Commentary Mar 2004 HMO-Dictated Patient Discharge, Commentary 2 Linda MacDonald Glenn, JD, LLM The financial constraints of HMOs often conflict with physicians' medical decisions regarding patient care. Virtual Mentor. 2004;6(3):112-116. doi: 10.1001/virtualmentor.2004.6.3.ccas3-0403.
Case and Commentary Mar 2004 HMO-Dictated Patient Discharge, Commentary 1 Lisa Anderson-Shaw, DrPH, MA, MSN The financial constraints of HMOs often conflict with physicians' medical decisions regarding patient care. Virtual Mentor. 2004;6(3):112-116. doi: 10.1001/virtualmentor.2004.6.3.ccas3-0403.
In the Literature Mar 2004 Leap-Frogging to Forgiveness Faith Lagay, PhD A journal author calls for physicians to admit to and repent for their medical mistakes, even in a no-blame environment. Virtual Mentor. 2004;6(3):117-119. doi: 10.1001/virtualmentor.2004.6.3.jdsc1-0403.
Case and Commentary Nov 2004 Clinical Trials and End-of-Life Decision Making, Commentary 2 Lucy Godley, MD, PhD Physicians can help oncology patients decide whether to focus on aggressive chemotherapy or less aggressive comfort measures for end-of-life care. Virtual Mentor. 2004;6(11):479-481. doi: 10.1001/virtualmentor.2004.6.11.ccas1-0411.